This model has the benefit of giving companies direct oversight of their in vivo studies, allowing them to move faster while operationalizing every dollar of their seed financing.
SAN FRANCISCO, Nov. 13, 2020 /PRNewswire/ -- Olema Oncology, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted ...
A-LabInsider released app to provide a central database of academic labs for biotech SMEsThe app is intended to provide real-time information about what is new in the marketCreates ...
In 2020, fundraising seems like an even bigger challenge than before. The biotech industry, however, is seeing a record high in capital raised to finance new therapeutic developments. ...
After founding Gossamer Bio $GOSS and handing the CEO’s reins to his longtime colleague and co-founder Sheila Gujrathi, biotech entrepreneur Faheem Hasnain is stepping back in to run the ...
If you’re contemplating changing careers in the midst of the COVID-19 pandemic, the reality is that if it’s time to make a change, there’s no time like the present.
The COVID-19 pandemic has put a spotlight on health inequities in our country, as minority populations are getting sick and dying at a disproportionate rate.
Dr Joanna Tripp, early career researcher at the Institute for Molecular Biosciences has now developed a new method to produce artificial organelles in living yeast cells. Joanna …